According to the ministry, around 315 to 450 senior citizens, aged 60 and above, are needed for the study, which will also test the effectiveness and safety of the vaccine for the group.
MOH said that the study is a collaboration between the Institute of Medical Biology, Chinese Academy of Medical Sciences (IMBCAMS), and the ministry.